Glycation products as markers and predictors of the progression of diabetic complications (Q36203971)

12 August 2017

1 reference

title

Glycation products as markers and predictors of the progression of diabetic complications (English)

1 reference

12 August 2017

Vincent M Monnier

1

1 reference

12 August 2017

David R Sell

series ordinal

2

1 reference

12 August 2017

Saul Genuth

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Annals of the New York Academy of Sciences

12 August 2017

published in

1 reference

12 August 2017

volume

1043

1 reference

12 August 2017

page(s)

567-581

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Nonenzymatic browning in vivo: possible process for aging of long-lived proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Accelerated age-related browning of human collagen in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Advanced glycation end products in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Removal of advanced glycation end products in clinical renal failure by peritoneal dialysis and haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Association between pentosidine and arteriosclerosis in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Structure elucidation of a novel yellow chromophore from human lens protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Lens autofluorescence is increased in newly diagnosed patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Simple non-invasive assessment of advanced glycation endproduct accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Advanced glycation end products and endothelial dysfunction in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Products of advanced glycation in patients with type 2 diabetes and vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Association between acute-phase reactants and advanced glycation end products in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Serum levels of low molecular weight advanced glycation end products in diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Advanced glycation end-products in patients with chronic alcohol misuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Antibodies to advanced glycation end products in children with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

Lens fluorescence and metabolic control in type 1 diabetic patients: a 14 year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1333.065

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1333.065

1 reference

12 August 2017

1 reference